Recoverin Rabbit Polyclonal Antibody

By Chemexpress June 9, 2025

Product Name :
Recoverin Rabbit Polyclonal Antibody

Predicted band size :

Observed band size :

Synonyms:
23 kDa photoreceptor cell-specific protein antibody Cancer associated retinopathy protein antibody Cancer-associated retinopathy protein antibody CAR antibody CAR protein antibody p26 antibody Protein CAR antibody RCV1 antibody RCVRN antibody RECO_HUMAN antibody 展开

Function :
This gene encodes a member of the recoverin family of neuronal calcium sensors. The encoded protein contains three calcium-binding EF-hand domains and may prolong the termination of the phototransduction cascade in the retina by blocking the phosphorylation of photo-activated rhodopsin. Recoverin may be the antigen responsible for cancer-associated retinopathy.

Antibody Type:
Rabbit Polyclonal Antibody

Immunogen :
The antiserum was produced against synthesized peptide derived from human Recoverin. AA range:107-156

Species reactivity:
Human, Mouse

Verify application:
WB, IHC-P, IF

Coupling :
unconjugated

Clone number:

RRID:

Form :
Liquid

Concentration :
1ug/ul

Storage instructions:
Store at +4℃ after thawing.92220-65-0 manufacturer Aliquot store at -20℃ or -80℃.879275-72-6 Formula Avoid repeated freeze / thaw cycles.PMID:33480421

Storage buffer solution:
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Subtype:
IgG

Purification method :
Immunogen affinity purified.

ELTSA :

Molecular weight :
23 kDa

Positive control :
Eye,Retina,Subthalamic nucleus,

By Chemexpress

Tis Meningitis 1 2 3 4 5 six 7 eight 9 10 388 224 204 73 62 58 25 20 19 15 119.9 69.2 63.1 22.6 19.2 17.9 7.7 six.two 5.9 four.six 2702 1912 1127 249 458 296 232 110 183 59 49.3 34.9 20.6 4.five 8.four 5.four four.2 two.0 three.three 1.1 two.43* (2.18, 2.71) 1.98* (1.72, 2.28) 3.07* (2.63, 3.56) 4.97* (three.77, 6.47) two.29* (1.73, 3.00) three.32* (two.46, 4.41) 1.83* (1.16, two.76) three.08* (1.81, four.99) 1.76* (1.04, two.83) four.31* (2.27, 7.69) 1 two 3 4 5 six 7 eight 9 10 1 2 3 4 5 six 7 eight 9 ten 620 421 267 219 101 81 78 76 66 62 396 256 101 80 62 39 38 36 33 32 191.6 130.1 82.5 67.7 31.two 25.0 24.1 23.five 20.four 19.two 122.four 79.1 31.two 24.7 19.two 12.1 11.7 11.1 10.two 9.9 7396 2978 3958 1283 1706 1224 700 265 761 336 5484 3897 1690 1213 723 347 773 641 276 639 134.9 54.three 72.two 23.four 31.1 22.3 12.eight 4.eight 13.9 6.1 one hundred.1 71.1 30.eight 22.1 13.two 6.3 14.1 11.7 five.0 11.7 1.42* (1.31, 1.54) 2.40* (two.16, 2.65) 1.14* (1.01, 1.29) two.89* (2.49, three.34) 1.00 (0.81, 1.23) 1.12 (0.88, 1.40) 1.89* (1.47, 2.39) four.86* (three.71, six.29) 1.47* (1.12, 1.89) three.13* (two.34, 4.11) 1.22* (1.ten, 1.36) 1.11 (0.98, 1.26) 1.01 (0.82, 1.24) 1.12 (0.88, 1.40) 1.45* (1.ten, 1.88) 1.90* (1.33, 2.66) 0.83 (0.58, 1.15) 0.95 (0.66, 1.33) two.03* (1.37, 2.91) 0.85 (0.58, 1.21)aWhite Rate Count Price AI/AN:White RR (95 CI

Chemexpress June 14, 2025

48. two. Elias AD: Triple-negative breast cancer. Am J Clin Oncol 2010, 33:637?45. 3. Carey LA

Chemexpress June 13, 2025

Ked immunosorbent assay approach with capture and detection antibodies in accordance with

Chemexpress June 12, 2025

Tis Meningitis 1 2 3 4 5 six 7 eight 9 10 388 224 204 73 62 58 25 20 19 15 119.9 69.2 63.1 22.6 19.2 17.9 7.7 six.two 5.9 four.six 2702 1912 1127 249 458 296 232 110 183 59 49.3 34.9 20.6 4.five 8.four 5.four four.2 two.0 three.three 1.1 two.43* (2.18, 2.71) 1.98* (1.72, 2.28) 3.07* (2.63, 3.56) 4.97* (three.77, 6.47) two.29* (1.73, 3.00) three.32* (two.46, 4.41) 1.83* (1.16, two.76) three.08* (1.81, four.99) 1.76* (1.04, two.83) four.31* (2.27, 7.69) 1 two 3 4 5 six 7 eight 9 10 1 2 3 4 5 six 7 eight 9 ten 620 421 267 219 101 81 78 76 66 62 396 256 101 80 62 39 38 36 33 32 191.6 130.1 82.5 67.7 31.two 25.0 24.1 23.five 20.four 19.two 122.four 79.1 31.two 24.7 19.two 12.1 11.7 11.1 10.two 9.9 7396 2978 3958 1283 1706 1224 700 265 761 336 5484 3897 1690 1213 723 347 773 641 276 639 134.9 54.three 72.two 23.four 31.1 22.3 12.eight 4.eight 13.9 6.1 one hundred.1 71.1 30.eight 22.1 13.two 6.3 14.1 11.7 five.0 11.7 1.42* (1.31, 1.54) 2.40* (two.16, 2.65) 1.14* (1.01, 1.29) two.89* (2.49, three.34) 1.00 (0.81, 1.23) 1.12 (0.88, 1.40) 1.89* (1.47, 2.39) four.86* (three.71, six.29) 1.47* (1.12, 1.89) three.13* (two.34, 4.11) 1.22* (1.ten, 1.36) 1.11 (0.98, 1.26) 1.01 (0.82, 1.24) 1.12 (0.88, 1.40) 1.45* (1.ten, 1.88) 1.90* (1.33, 2.66) 0.83 (0.58, 1.15) 0.95 (0.66, 1.33) two.03* (1.37, 2.91) 0.85 (0.58, 1.21)aWhite Rate Count Price AI/AN:White RR (95 CI

48. two. Elias AD: Triple-negative breast cancer. Am J Clin Oncol 2010, 33:637?45. 3. Carey LA

Ked immunosorbent assay approach with capture and detection antibodies in accordance with

Recoverin Rabbit Polyclonal Antibody